Pharma Co. Clarus Gets OK For Ch. 11 Drug Sale
By Rick Archer · October 26, 2022, 2:09 PM EDT
A Delaware bankruptcy judge on Wednesday approved drug company Clarus Therapeutics' sale of its sole product for $7.25 million in cash and tens of millions in potential future royalties and payments....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login